"The government should step in to facilitate lower prices, as has occurred in the rest of the world," writes one reader.

Unshrunk: A Story of Psychiatric Treatment Resistance, the newly published book by Laura Delano, is scaring the hell out of ...

Tariffs will trigger some job losses, and impact future investment, but Ireland’s strategic value remains solid - ‘Pharma isn ...

We've got big players, we've got the pharma factor, we've got the tobacco industry, and we've got the alcohol industry, and I ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

The head of one of America's largest pharmaceutical companies says he does not support tariffs on Australian medicines as US President Donald Trump considers more trade restrictions.

On 'The Adam Carolla Show' podcast, healthcare industry watchdog and wellness expert Calley Means shares why he believes the left used to question pharmaceutical companies, big institutions, and war ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

We haven’t had much occasion to see our leaders put to the test. But the Trump administration is making strict demands that aren’t easy to meet.

Big pharma coming after the PBS is a compliment — it shows that the scheme works in the best interests of people, not the markets.

For Gov. Glenn Youngkin, sinking fast in a political quagmire of his own making, the misery of federal employees in Virginia is a measure of his multimillion-dollar fortune. Schapiro: Assembly ...